相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Heme Oxygenase-1 Upregulation: A Novel Approach in the Treatment of Cardiovascular Disease
Lars Bellner et al.
ANTIOXIDANTS & REDOX SIGNALING (2020)
Heme-Oxygenase-1
Maria M. Facchinetti
ANTIOXIDANTS & REDOX SIGNALING (2020)
Heme Oxygenase Dependent Bilirubin Generation in Vascular Cells: A Role in Preventing Endothelial Dysfunction in Local Tissue Microenvironment?
Mariapaola Nitti et al.
FRONTIERS IN PHYSIOLOGY (2020)
Canagliflozin inhibits vascular smooth muscle cell proliferation and migration: Role of heme oxygenase-1
Ghazaleh Behnammanesh et al.
REDOX BIOLOGY (2020)
Bardoxolone methyl: drug development for diabetic kidney disease
Hironori Kanda et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2020)
Pro-inflammatory Actions of Heme and Other Hemoglobin-Derived DAMPs
Marcelo T. Bozza et al.
FRONTIERS IN IMMUNOLOGY (2020)
Therapeutic effects of CO-releaser/Nrf2 activator hybrids (HYCOs) in the treatment of skin wound, psoriasis and multiple sclerosis
Zeina El Ali et al.
REDOX BIOLOGY (2020)
Smooth Muscle Cells Contribute the Majority of Foam Cells in ApoE (Apolipoprotein E)-Deficient Mouse Atherosclerosis
Ying Wang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Smooth Muscle Cell Phenotypic Diversity At the Crossroads of Lineage Tracing and Single-Cell Transcriptomics
Mingjun Liu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
The Protective Role of Heme Oxygenase-1 in Atherosclerotic Diseases
Yoshimi Kishimoto et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
HO-1 overexpression and underexpression: Clinical implications
George S. Drummond et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2019)
Dimethyl fumarate ameliorates acetaminophen-induced hepatic injury in mice dependent of Nrf-2/HO-1 pathway
Rehab S. Abdelrahman et al.
LIFE SCIENCES (2019)
Bilirubin coating attenuates the inflammatory response to everolimus-coated stents
In-Ho Bae et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2018)
Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness
Andrew L. Durham et al.
CARDIOVASCULAR RESEARCH (2018)
Arterial smooth muscle dynamics in development and repair
Urmas Roostalu et al.
DEVELOPMENTAL BIOLOGY (2018)
Overcoming safety challenges in CO therapy - Extracorporeal CO delivery under precise feedback control of systemic carboxyhemoglobin levels
Jakob Wollborn et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Where is the Clinical Breakthrough of Heme Oxygenase-1 / Carbon Monoxide Therapeutics?
Christopher P. Hopper et al.
CURRENT PHARMACEUTICAL DESIGN (2018)
Oral carbon monoxide therapy in murine sickle cell disease: Beneficial effects on vaso-occlusion, inflammation and anemia
John D. Belcher et al.
PLOS ONE (2018)
Intravenous Heme Arginate Induces HO-1 (Heme Oxygenase-1) in the Human Heart: Randomized, Placebo-Controlled, Safety, and Feasibility Pharmacokinetic StudyBrief Report
Martin Andreas et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2018)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Bilirubin Prevents Atherosclerotic Lesion Formation in Low-Density Lipoprotein Receptor-Deficient Mice by Inhibiting Endothelial VCAM-1 and ICAM-1 Signaling
Megan E. Vogel et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2017)
CO-releasing molecules CORM2 attenuates angiotensin II-induced human aortic smooth muscle cell migration through inhibition of ROS/IL-6 generation and matrix metalloproteinases-9 expression
Ming-Horng Tsai et al.
REDOX BIOLOGY (2017)
Heart Disease and Stroke Statistics-2017 Update A Report From the American Heart Association
Emelia J. Benjamin et al.
CIRCULATION (2017)
Biological signaling by carbon monoxide and carbon monoxide-releasing molecules
Roberto Motterlini et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2017)
Bilirubin Nanoparticles as a Nanomedicine for Anti-inflammation Therapy
Yonghyun Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Heme oxygenase-l-derived bilirubin counteracts HIV protease inhibitor-mediated endothelial cell dysfunction
Xiao-Ming Liu et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Diverse Nrf2 Activators Coordinated to Cobalt Carbonyls Induce Heme Oxygenase-1 and Release Carbon Monoxide in Vitro and in Vivo
Aniket Nikam et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis
A. E. Bharucha et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2016)
HEME OXYGENASES IN CARDIOVASCULAR HEALTH AND DISEASE
Anita Ayer et al.
PHYSIOLOGICAL REVIEWS (2016)
A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1
Lu Kang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)
Controlled therapeutic gas delivery systems for quality-improved transplants
Christoph Steiger et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2015)
Recent insights into the cellular biology of atherosclerosis
Ira Tabas et al.
JOURNAL OF CELL BIOLOGY (2015)
Delayed inhaled carbon monoxide mediates the regression of established neointimal lesions
Michael Madigan et al.
JOURNAL OF VASCULAR SURGERY (2015)
Atorvastatin treatment increases plasma bilirubin but not HMOX1 expression in stable angina patients
Bosa Mirjanic-Azaric et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2015)
Erythropoietin attenuates pulmonary vascular remodeling in experimental pulmonary arterial hypertension through interplay between endothelial progenitor cells and heme oxygenase
Rosa Laura E. van loon et al.
FRONTIERS IN PEDIATRICS (2015)
Heme oxygenase-1 regulates cell proliferation via carbon monoxide-mediated inhibition of T-type Ca2+ channels
Hayley Duckles et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2015)
Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions
Attarat Pattanawongsa et al.
DRUG METABOLISM AND DISPOSITION (2015)
Association Between Heme Oxygenase 1 Gene Promoter Polymorphisms and Susceptibility to Coronary Artery Disease: A HuGE Review and Meta-Analysis
Huaiyu Qiao et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2014)
Heme Oxygenase-1: A Metabolic Nike
Barbara Wegiel et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
p21-Dependent Protective Effects of a Carbon Monoxide-Releasing Molecule-3 in Pulmonary Hypertension
Shariq Abid et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
A click-and-release approach to CO prodrugs
Danzhu Wang et al.
CHEMICAL COMMUNICATIONS (2014)
Contribution of Intimal Smooth Muscle Cells to Cholesterol Accumulation and Macrophage-Like Cells in Human Atherosclerosis
Sima Allahverdian et al.
CIRCULATION (2014)
Nuclear Heme Oxygenase-1 (HO-1) Modulates Subcellular Distribution and Activation of Nrf2, Impacting Metabolic and Anti-oxidant Defenses
Chhanda Biswas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Effects of aspirin & simvastatin and aspirin, simvastatin, & lipoic acid on heme oxygenase-1 in healthy human subjects
Adil E. Bharucha et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2014)
Therapeutic uses of animal biles in traditional Chinese medicine: An ethnopharmacological, biophysical chemical and medicinal review
David Q-H Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Dimethylfumarate attenuates restenosis after acute vascular injury by cell-specific and Nrf2-dependent mechanisms
Chang Joo Oh et al.
REDOX BIOLOGY (2014)
Potential Therapeutic Effects of Natural Heme Oxygenase-1 Inducers in Cardiovascular Diseases
Ignazio Barbagallo et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Docosahexaenoic acid (DHA)-induced heme oxygenase-1 attenuates cytotoxic effects of DHA in vascular smooth muscle cells
Gabriel Stulnig et al.
ATHEROSCLEROSIS (2013)
Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial
F. J. Lavalle-Gonzalez et al.
DIABETOLOGIA (2013)
Biliverdin reductase/bilirubin mediates the anti-apoptotic effect of hypoxia in pulmonary arterial smooth muscle cells through ERK1/2 pathway
Shasha Song et al.
EXPERIMENTAL CELL RESEARCH (2013)
Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial
William T. Cefalu et al.
LANCET (2013)
Length polymorphisms of heme oxygenase-1 determine the effect of far-infrared therapy on the function of arteriovenous fistula in hemodialysis patients: a novel physicogenomic study
Chih-Ching Lin et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2013)
Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease
Dick de Zeeuw et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
PDGF-Induced Migration of Vascular Smooth Muscle Cells Is Inhibited by Heme Oxygenase-1 Via VEGFR2 Upregulation and Subsequent Assembly of Inactive VEGFR2/PDGFRβ Heterodimers
Caroline Cheng et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Sildenafil stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells via distinct signaling pathways
Xiao-ming Liu et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Vascular Remodeling in Hypertension Mechanisms and Treatment
Ernesto L. Schiffrin
HYPERTENSION (2012)
Interleukin-19 (IL-19) Induces Heme Oxygenase-1 (HO-1) Expression and Decreases Reactive Oxygen Species in Human Vascular Smooth Muscle Cells
Khatuna Gabunia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Essential Roles of Raf/Extracellular Signal-regulated Kinase/Mitogen-activated Protein Kinase Pathway, YY1, and Ca2+ Influx in Growth Arrest of Human Vascular Smooth Muscle Cells by Bilirubin
Marlon Stoeckius et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Molecular pathogenesis of pulmonary arterial hypertension
Marlene Rabinovitch
JOURNAL OF CLINICAL INVESTIGATION (2012)
Bilirubin inhibits neointma formation and vascular smooth muscle cell proliferation and migration
Kelly J. Peyton et al.
FRONTIERS IN PHARMACOLOGY (2012)
Mechanisms of arterial remodeling: lessons from genetic diseases
Bernard J. van Varik et al.
Frontiers in Genetics (2012)
The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus
Douwe Dekker et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Caveolin-1 Is a Competitive Inhibitor of Heme Oxygenase-1 (HO-1) with Heme: Identification of a Minimum Sequence in Caveolin-1 for Binding to HO-1
Junichi Taira et al.
BIOCHEMISTRY (2011)
Ex vivo carbon monoxide delivery inhibits intimal hyperplasia in arterialized vein grafts
Atsunori Nakao et al.
CARDIOVASCULAR RESEARCH (2011)
Heme oxygenase-1 inhibits progression and destabilization of vulnerable plaques in a rabbit model of atherosclerosis
Li Tingting et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2011)
Simvastatin protects against the development of monocrotaline-induced pulmonary hypertension in rats via a heme oxygenase-1-dependent pathway
Wei-hua Zhang et al.
EXPERIMENTAL LUNG RESEARCH (2011)
Protective role of heme oxygenase-1 against inflammation in atherosclerosis
William Durante
FRONTIERS IN BIOSCIENCE-LANDMARK (2011)
Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes
Pablo E. Pergola et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Regional and systemic hemodynamic responses following the creation of a murine arteriovenous fistula
Lu Kang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2011)
Celastrol Attenuates Hypertension-Induced Inflammation and Oxidative Stress in Vascular Smooth Muscle Cells via Induction of Heme Oxygenase-1
Xiao Yu et al.
AMERICAN JOURNAL OF HYPERTENSION (2010)
HO-1 and CO Decrease Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cell Migration Via Inhibition of Nox1
Andres I. Rodriguez et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
First-in-Human Study Demonstrating Pharmacological Activation of Heme Oxygenase-1 in Humans
A. E. Bharucha et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Targeting Heme Oxygenase-1 in Vascular Disease
William Durante
CURRENT DRUG TARGETS (2010)
Interaction of Carbon Monoxide with Transition Metals: Evolutionary Insights into Drug Target Discovery
Roberta Foresti et al.
CURRENT DRUG TARGETS (2010)
Upregulation of Heme Oxygenase-1 Inhibits the Maturation and Mineralization of Osteoblasts
Tzu-Hung Lin et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Hemin prevents in-stent stenosis in rat and rabbit models by inducing heme-oxygenase-1
Jean-Marc Hyvelin et al.
JOURNAL OF VASCULAR SURGERY (2010)
A Central Role for Free Heme in the Pathogenesis of Severe Sepsis
Rasmus Larsen et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Heme Oxygenase 1 Determines Atherosclerotic Lesion Progression Into a Vulnerable Plaque
Caroline Cheng et al.
CIRCULATION (2009)
Ferritin Prevents Calcification and Osteoblastic Differentiation of Vascular Smooth Muscle Cells
Abolfazl Zarjou et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)
Divergent Cardiopulmonary Actions of Heme Oxygenase Enzymatic Products in Chronic Hypoxia
Sally H. Vitali et al.
PLOS ONE (2009)
Simvastatin ameliorates established pulmonary hypertension through a heme oxygenase-I dependent pathway in rats
Hsao-Hsun Hsu et al.
RESPIRATORY RESEARCH (2009)
Far infrared therapy inhibits vascular endothelial inflammation via the induction of heme oxygenase-1
Chih-Ching Lin et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk:: Possible protective effects and therapeutic applications of bilirubin
Harvey A. Schwertner et al.
ATHEROSCLEROSIS (2008)
Inducers of heme oxygenase-1
M. L. Ferrandiz et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Serum bilirubin and ferritin levels link heme oxygenase-1 gene promoter polymorphism and susceptibility to coronary artery disease in diabetic patients
Ying-Hwa Chen et al.
DIABETES CARE (2008)
Pathogenic mechanisms of pulmonary arterial hypertension
Stephen Y. Chan et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)
HOming in on arteriovenous fistula survival
W. Durante et al.
KIDNEY INTERNATIONAL (2008)
Genetic deficiency of heme oxygenase-1 impairs functionality and form of an arteriovenous fistula in the mouse
J. P. Juncos et al.
KIDNEY INTERNATIONAL (2008)
Hemin Treatment Abrogates Monocrotaline-Induced Pulmonary Hypertension
K. Shimzu et al.
MEDICINAL CHEMISTRY (2008)
Adenovirus-mediated heme oxygenase transfer inhibits graft arteriosclerosis in rat aortic transplants
D. Du et al.
TRANSPLANTATION PROCEEDINGS (2007)
Improved myocardial function after cold storage with preservation solution supplemented with a carbon monoxide-releasing molecule (CORM-3)
Muntaser D. Musameh et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2007)
Expression and characterization of full-length human heme oxygenase-1: The presence of intact membrane-binding region leads to increased binding affinity for NADPH cytochrome P450 reductase
Warren J. Huber et al.
BIOCHEMISTRY (2007)
Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats
Takayuki Ito et al.
CIRCULATION RESEARCH (2007)
Nitric oxide stimulates heme oxygenase-1 gene transcription via the Nrf2/ARE complex to promote vascular smooth muscle cell survival
Xiao-ming Liu et al.
CARDIOVASCULAR RESEARCH (2007)
Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria
Ana Pamplona et al.
NATURE MEDICINE (2007)
Butylated hydroxyanisole stimulates heme oxygenase-1 gene expression and inhibits neointima formation in rat arteries
Xiao-ming Liu et al.
CARDIOVASCULAR RESEARCH (2007)
Heme oxygenase-1 gene promoter polymorphism and restenosis following coronary stenting
Klaus Tiroch et al.
EUROPEAN HEART JOURNAL (2007)
Far-infrared therapy: A novel treatment to improve access blood flow and unassisted patency of arteriovenous fistula in hemodialysis patients
Chih-Ching Lin et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Inhaled carbon monoxide prevents graft-induced intimal hyperplasia in swine
Basel Ramlawi et al.
JOURNAL OF SURGICAL RESEARCH (2007)
Bilirubin and biliverdin treatment of atherosclerotic diseases
Robert Oellinger et al.
CELL CYCLE (2007)
Preconditioning with low concentration NO attenuates subsequent NO-induced apoptosis in vascular smooth muscle cells via HO-1-dependent mitochondrial death pathway
Hyun-Jeong Kwak et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2006)
Allograft vasculopathy versus atherosclerosis
Maziar Rahmani et al.
CIRCULATION RESEARCH (2006)
Carbon monoxide reverses established pulmonary hypertension
Brian S. Zuckerbraun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Protection of human vascular smooth muscle cells from H2O2-induced apoptosis through functional codependence between HO-1 and AKT
Keith R. Brunt et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism (vol 20, pg 1236, 2006)
Daniela P. Converso et al.
FASEB JOURNAL (2006)
HO-1 is located in liver mitochondria and modulates mitochondrial heme content and metabolism
Daniela P. Converso et al.
FASEB JOURNAL (2006)
Length polymorphism in heme oxygenase-1 is associated with arteriovenous fistula patency in hemodialysis patients
CC Lin et al.
KIDNEY INTERNATIONAL (2006)
Heme oxygenase-1 mediates the protective effects of rapamycin in monocrotaline-induced pulmonary hypertension
HL Zhou et al.
LABORATORY INVESTIGATION (2006)
The emerging role of vascular smooth muscle cell apoptosis in atherosclerosis and plaque stability
Murray Clarke et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
In vitro inhibition of UDP glucuronosyltransferases by atazanavir and other HIV protease inhibitors and the relationship of this property to in vivo bilirubin glucuronidation
DL Zhang et al.
DRUG METABOLISM AND DISPOSITION (2005)
Bilirubin -: A natural inhibitor of vascular smooth muscle cell proliferation
R Öllinger et al.
CIRCULATION (2005)
Caveolin-1 expression by means of p38β mitogen-activated protein kinase mediates the antiproliferative effect of carbon monoxide
HP Kim et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Biliverdin administration prevents the formation of intimal hyperplasia induced by vascular injury
A Nakao et al.
CIRCULATION (2005)
Heme oxygenase and the cardiovascular-renal system
NG Abraham et al.
FREE RADICAL BIOLOGY AND MEDICINE (2005)
Interleukin 10 attenuates neointimal proliferation and inflammation in aortic allografts by a heme oxygenase-dependent pathway
SF Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Continuous inhalation of carbon monoxide attenuates hypoxic pulmonary hypertension development presumably through activation of BKCa channels
E Dubuis et al.
CARDIOVASCULAR RESEARCH (2005)
Endoplasmic reticulum stress stimulates heme oxygenase-1 gene expression in vascular smooth muscle - Role in cell survival
XM Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese
K Ono et al.
ATHEROSCLEROSIS (2004)
Heme oxygenase-1 genotype and restenosis after balloon angioplasty:: A novel vascular protective factor
M Schillinger et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2004)
Effects of endogenous carbon monoxide on collagen synthesis in pulmonary artery in rats under hypoxia
LM Gong et al.
LIFE SCIENCES (2004)
Probucol protects against smooth muscle cell proliferation by upregulating heme oxygenase-1
YM Deng et al.
CIRCULATION (2004)
Haem oxygenase-1: a target for dietary antioxidants
RM Ogborne et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2004)
Molecular regulation of vascular smooth muscle cell differentiation in development and disease
GK Owens et al.
PHYSIOLOGICAL REVIEWS (2004)
Caveolae compartmentalization of heme oxygenase-1 in endothelial cells
HP Kim et al.
FASEB JOURNAL (2004)
Heme oxygenase-1 gene promotor microsatellite polymorphism is associated with angiographic restenosis after coronary stenting
YH Chen et al.
EUROPEAN HEART JOURNAL (2004)
The role of heme oxygenase-1 promoter polymorphisms in human disease
M Exner et al.
FREE RADICAL BIOLOGY AND MEDICINE (2004)
Evidence for heme oxygenase-1 association with caveolin-1 and-2 in mouse mesangial cells
NH Jung et al.
IUBMB LIFE (2003)
Absence of heme oxygenase-1 exacerbates atherosclerotic lesion formation and vascular remodeling
SF Yet et al.
FASEB JOURNAL (2003)
Antiapoptotic action of carbon monoxide on cultured vascular smooth muscle cells
XM Liu et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2003)
Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells - Implications in the antiproliferative response to rapamycin
GA Visner et al.
CIRCULATION (2003)
Carbon monoxide suppresses arteriosclerotic lesions associated with chronic graft rejection and with balloon injury
LE Otterbein et al.
NATURE MEDICINE (2003)
Transcriptional regulation of the heme oxygenase-1 gene via the stress response element pathway
J Alam et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Vascular proliferation and atherosclerosis: New perspectives and therapeutic strategies
VJ Dzau et al.
NATURE MEDICINE (2002)
Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene
JY Sun et al.
EMBO JOURNAL (2002)
Heme oxygenase-1 gene promoter polymorphism is associated with coronary artery disease in Japanese patients with coronary risk factors
H Kaneda et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Differential effect of heme oxygenase-1 in endothelial and smooth muscle cell cycle progression
GL Volti et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Gene transfer of heme oxygenase-1 and carbon monoxide delivery inhibit chronic rejection
C Chauveau et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2002)
Carbon monoxide inhibits apoptosis in vascular smooth muscle cells
XM Liu et al.
CARDIOVASCULAR RESEARCH (2002)
Microsatellite polymorphism in promoter of heme oxygenase-1 gene is associated with susceptibility to coronary artery disease in type 2 diabetic patients
YH Chen et al.
HUMAN GENETICS (2002)
Heme oxygenase-1-derived carbon monoxide is an autocrine inhibitor of vascular smooth muscle cell growth
KJ Peyton et al.
BLOOD (2002)
Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation
M Zhang et al.
CELL RESEARCH (2002)
Inhibition of graft arteriosclerosis development in rat aortas following heme oxygenase-1 gene transfer
D Bouchet et al.
TRANSPLANT IMMUNOLOGY (2002)
Adenovirus-mediated heme oxygenase-1 gene expression stimulates apoptosis in vascular smooth muscle cells
XM Liu et al.
CIRCULATION (2002)
Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation
DA Tulis et al.
CIRCULATION (2001)
Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension
TK Jeffery et al.
PHARMACOLOGY & THERAPEUTICS (2001)
Targeted expression of heme oxygenase-1 prevents the pulmonary inflammatory and vascular responses to hypoxia
T Minamino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Heme oxygenase-1 protects against vascular constriction and proliferation
HJ Duckers et al.
NATURE MEDICINE (2001)
Heme oxygenase-1 attenuates vascular remodeling following balloon injury in rat carotid arteries
DA Tulis et al.
ATHEROSCLEROSIS (2001)
Real-time measurements of endogenous CO production from vascular cells using an ultrasensitive laser sensor
Y Morimoto et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2001)
Prevention of hypoxia-induced pulmonary hypertension by enhancement of endogenous heme oxygenase-1 in the rat
H Christou et al.
CIRCULATION RESEARCH (2000)
Protective roles of endogenous-carbon monoxide in neointimal development elicited by arterial injury
Y Togane et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)
分享论文
